3 assays pending, so why jump the gun? Another survey to be done, so plenty more exploration to be done. Nothing happens in a hurry.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025